Zobrazeno 1 - 10 of 13 pro vyhledávání: '"del Alba, AG"'
3
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment
Autor: del Alba, AG, Arranz, JA, Puente, J, Mendez-Vidal, MJ, Gallardo, E, Grande, E, Perez-Valderrama, B, Gonzalez-Billalabeitia, E, Lazaro-Quintela, M, Pinto, A, Lainez, N, Piulats, JM, Esteban, E, Rey, JPM, Garcia, JA, Suarez, C
Publikováno v: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Updated information published up to 2016 regarding major advances in renal cancer, bladder cancer, and prostate cancer is here presented. Based on an ever better understanding of the genetic and molecular alterations that govern the initial pathogeni
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::87e1158e8288d8ff5484fcfb049e4619
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6484
Zobrazit plný text záznamu
4
Evaluation of patients with metastatic renal cell carcinoma after failure of first-line treatment
Autor: Carles, J, Chirivella, I, Climent, MA, Gallardo, E, del Alba, AG, Maroto, JP, Mellado, B, del Muro, FXG
Publikováno v: CANCER AND METASTASIS REVIEWS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
The approval and use of molecular targeted agents for the first-line treatment of metastatic renal cell carcinoma (mRCC) has substantially improved the clinical outcome of patients. Although eventually all patients progress, hopes have been renewed w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::da51d37333d004cee870eb6c68406b75
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11148
Zobrazit plný text záznamu
5
Recomendations on the Management of Controversies in Advanced Castrate-Resistant Prostate Cancer
Autor: Cozar, JM, Solsona, E, Morote, J, Minana, B, Maroto, JP, del Alba, AG, Climent, MA, Carles, J, Alcaraz, A, Castellano, D
Publikováno v: Actas Urologicas Espanolas
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Context: Controversies and uncertainties among integral management of advanced castration resistant prostate cancer continue to exist despite the number of evidence based clinical practice guidelines published with high international consensus. Objec
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c0c43ce9490e973c053276cebaf82b5a
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11047
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Sex differences in the diagnosis, treatment and prognosis of cancer: the rationale for an individualised approach.
Autor: Vera R; Department of Medical Oncology, University Hospital of Navarra, Pamplona. IdiSNA, Navarra's Health Research Institute, Irunlarrea 3, 31190, Pamplona, Spain. rveragar@cfnavarra.es., Juan-Vidal O; Department of Medical Oncology, University Hospital La Fe, Valencia, Spain., Safont-Aguilera MJ; Department of Medical Oncology, University General Hospital of Valencia, Valencia University, Valencia. CIBERONC, Valencia, Spain., de la Peña FA; Medical Oncology, Department of Haematology and Oncology, University General Hospital Morales Meseguer, Murcia, Spain., Del Alba AG; Genitourinary Tumour Unit, Department of Medical Oncology, University Hospital Puerta de Hierro, Majadahonda, Madrid, Spain.
Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Jul; Vol. 25 (7), pp. 2069-2076. Date of Electronic Publication: 2023 Feb 18.
Zobrazit plný text záznamu
8
Akademický článek
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era.
Autor: Bellmunt J; University Hospital del Mar, Barcelona, Spain. Electronic address: jbellmunt@parcdesalutmar.cat., Esteban E; Hospital Universitario Central de Asturias, Oviedo, Spain., Del Muro XG; Instituto Catalán de Oncología, IDIBELL, Barcelona, Spain., Sepúlveda JM; Hospital Universitario 12 de Octubre, Madrid, Spain., Maroto P; Hospital de Sant Pau, Barcelona, Spain., Gallardo E; Institut d'Investigació i Innovació Parc Taulí, Parc Taulí Hospital Universitari, Barcelona, Spain., Del Alba AG; Servicio de Oncologia Médica, Hospital Universitario Son Dureta, Palma de Mallorca, Spain., Etxaniz O; Instituto Catalán de Oncología, Badalona, Spain., Guix M; University Hospital del Mar, Barcelona, Spain., Larriba JLG; Hospital Clínico San Carlos, Madrid, Spain., Arranz JA; Hospital Gregorio Marañón, Madrid, Spain., Redrado M; CIBERONC/IDISNA Program of Solid Tumours and Biomarkers, CIMA and Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain., Calvo A; CIBERONC/IDISNA Program of Solid Tumours and Biomarkers, CIMA and Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain.
Publikováno v: European urology oncology [Eur Urol Oncol] 2021 Jun; Vol. 4 (3), pp. 502-505. Date of Electronic Publication: 2019 Aug 30.
Zobrazit plný text záznamu
9
Akademický článek
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer.
Autor: Marín-Aguilera M; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain., Reig Ò; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain., Milà-Guasch M; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain., Font A; Department of Medical Oncology, Institut Català d'Oncologia, Badalona, Spain., Domènech M; Department of Medical Oncology, Fundació Althaia, Barcelona, Spain., Rodríguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain., Carles J; Department of Medical Oncology, Vall d'Hebron Institute of Oncology. Vall d'Hebron University Hospital, Barcelona, Spain., Suárez C; Department of Medical Oncology, Vall d'Hebron Institute of Oncology. Vall d'Hebron University Hospital, Barcelona, Spain., Del Alba AG; Department of Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Jiménez N; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain., Victoria I; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain., Sala-González N; Department of Medical Oncology, Institut Català d'Oncologia, Girona, Spain., Ribal MJ; Department of Urology, Hospital Clinic, Barcelona, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain., López S; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain., Etxaniz O; Department of Medical Oncology, Institut Català d'Oncologia, Badalona, Spain., Anguera G; Department of Medical Oncology, Hospital de la Santa Cruz y San Pablo, Barcelona, Spain., Maroto P; Department of Medical Oncology, Hospital de la Santa Cruz y San Pablo, Barcelona, Spain., Fernández PL; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain.; Department of Pathology, Hospital Clínic, Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain., Mellado B; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory, Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Publikováno v: International journal of cancer [Int J Cancer] 2019 Oct 01; Vol. 145 (7), pp. 1970-1981. Date of Electronic Publication: 2019 Mar 23.
Zobrazit plný text záznamu
10
Akademický článek
Radium-223 international early access program: results from the Spanish subset.
Autor: Carles J; Department of Medical Oncology, Hospital Universitario Vall d'Hebrón, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain., Méndez MJ; Department of Medical Oncology, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, 14004 Córdoba, Spain., Pinto Á; Department of Medical Oncology, Hospital Universitario la Paz, 28046 Madrid, Spain., Sáez MI; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain., Arranz JA; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain., Maroto P; Department of Medical Oncology, Hospital de la Santa Cruz y San Pablo, 08041 Barcelona, Spain., López-Criado P; Department of Medical Oncology, MD Anderson Cancer Center, 28033 Madrid, Spain., Mellado B; Department of Medical Oncology, Hospital Clínico y Provincial, 08036 Barcelona, Spain., Donas JG; Department of Medical Oncology, CIOCC, 28050 Madrid, Spain., Hernando S; Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain., León L; Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago, 15706 Santiago de Compostela, Spain., Del Alba AG; Department of Medical Oncology, Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain., Laínez N; Department of Medical Oncology, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain., Esteban E; Department of Medical Oncology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain., Reynés G; Department of Medical Oncology, Hospital Universitario y Politécnico la Fe, 46026 Valencia, Spain., Pérez-Gracia JL; Department of Medical Oncology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., Germà JR; Department of Medical Oncology, Instituto Catalán de Oncología, 08908 Hospitalet de Llobregat, Spain., López-Brea M; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain., Pérez-Valderrama B; Department of Medical Oncology, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain., Moretones C; Bayer Hispania SL, 08970 Barcelona, Spain., Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Publikováno v: Future oncology (London, England) [Future Oncol] 2018 Jan; Vol. 14 (1), pp. 41-50. Date of Electronic Publication: 2017 Dec 13.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje